Patil Chirag G, Veeravagu Anand, Prevedello Daniel M, Katznelson Laurence, Vance Mary L, Laws Edward R
Department of Neurosurgery, Stanford University School of Medicine, Stanford, California, USA.
Neurosurgery. 2008 Aug;63(2):266-70; discussion 270-1. doi: 10.1227/01.NEU.0000313117.35824.9F.
To systematically analyze patient outcomes after repeat transsphenoidal (TS) surgery for recurrent Cushing's disease.
We retrospectively reviewed records of all patients with recurrent Cushing's disease who underwent repeat TS surgery for resection of a pituitary corticotroph adenoma at the University of Virginia Medical Center from 1992 to 2006. Remission at follow-up was defined as a normal postoperative 24-hour urine free cortisol, or continued need for glucocorticoid replacement after repeat TS surgery. Recurrence of the disease was defined as an elevated 24-hour urine free cortisol with clinical symptoms consistent with Cushing's disease while not receiving glucocorticoid replacement. Multivariate logistic regression was performed to evaluate the effect of potential predictors on remission. Recurrence rates, subsequent treatments, and the final endocrine status of the patients are presented.
We identified 36 patients who underwent repeat TS surgery for recurrent Cushing's disease. The mean age of the patients was 40.3 years (range, 17.1-63.0 yr), and 26 were women. The median time to recurrence after initial successful TS surgery was 36 months (range, 4 mo-16 yr). Remission after repeat TS surgery was observed in 22 (61%) of the 36 patients. During the same time period, of the 338 patients who underwent first-time TS surgery for Cushing's disease, remission was achieved in 289 (85.5%). The odds of failure (to achieve remission) for patients with repeat TS surgery for recurrent Cushing's disease were 3.7 times that of patients undergoing first-time TS surgery (odds ratio, 3.7; 95% confidence interval, 1.8-7.8). Two of the 22 patients with successful repeat TS surgery had a second recurrence at 6 and 11 months, respectively. Complete biochemical and clinical remission after stereotactic radiosurgery, adrenalectomy, and ongoing ketoconazole therapy was achieved in 30 (83.3%) of the 36 patients, and active disease continued in 6 patients (16.7%).
Although the success of repeat TS surgery for recurrence of Cushing's disease is less than that of initial surgery, a second procedure offers a reasonable possibility of immediate remission. If the operation is not successful, other treatments, including pituitary radiation, medical therapy, and even bilateral adrenalectomy, are required.
系统分析复发性库欣病再次经蝶窦(TS)手术后的患者预后。
我们回顾性分析了1992年至2006年在弗吉尼亚大学医学中心因垂体促肾上腺皮质激素腺瘤切除而接受再次TS手术的所有复发性库欣病患者的记录。随访时的缓解定义为术后24小时尿游离皮质醇正常,或再次TS手术后仍需继续使用糖皮质激素替代治疗。疾病复发定义为在未接受糖皮质激素替代治疗时,24小时尿游离皮质醇升高且伴有与库欣病一致的临床症状。进行多因素逻辑回归分析以评估潜在预测因素对缓解的影响。列出了复发率、后续治疗情况以及患者的最终内分泌状态。
我们确定了36例因复发性库欣病接受再次TS手术的患者。患者的平均年龄为40.3岁(范围17.1 - 63.0岁),其中26例为女性。初次TS手术成功后复发的中位时间为36个月(范围4个月 - 16年)。36例患者中有22例(61%)在再次TS手术后实现缓解。在同一时期,338例因库欣病接受首次TS手术的患者中,289例(85.5%)实现缓解。复发性库欣病患者再次TS手术失败(未实现缓解)的几率是接受首次TS手术患者的3.7倍(比值比3.7;95%置信区间1.8 - 7.8)。22例再次TS手术成功的患者中有2例分别在6个月和11个月时出现第二次复发。36例患者中有30例(83.3%)在立体定向放射外科手术、肾上腺切除及持续酮康唑治疗后实现了完全生化和临床缓解,6例患者(16.7%)疾病仍处于活动状态。
尽管复发性库欣病再次TS手术的成功率低于初次手术,但二次手术仍有合理的可能性实现即刻缓解。如果手术不成功,则需要其他治疗,包括垂体放疗、药物治疗,甚至双侧肾上腺切除。